Back to Search Start Over

SF1-4 from Treatment of Pancreatic Cancer Patient–Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin

Authors :
Chi V. Dang
Anirban Maitra
Manuel Hidalgo
Fátima Al-Shahrour
Héctor Tejero
Joshua D. Rabinowitz
Jurre J. Kamphorst
Elizabeth De Oliveira
Shweta G. Pai
Shinichi Yabuuchi
N.V. Rajeshkumar
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

SF 1. Heat map showing the tumor growth inhibition (TGI) of six metabolic inhibitors in PDX panel. SF 2. Tumor growth curves of PDXs treated with phenformin. SF 3. Tumor doubling time of 12 individual PDXs. SF 4. Aggregate tumor doubling time of PDXs treated with vehicle or phenformin.

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....2aff6cabfe1685785d8cd3b8aca1963d
Full Text :
https://doi.org/10.1158/1078-0432.22468770